PEAK6 Investments’s iShares US Medical Devices ETF IHI Stock Holding History

PEAK6 Investments’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-339	Closed	-$17K	–	5487
2022 Q2	$17K	Sell	339 -2,450	-88%	-$134K	﹤0.01%	5757
2022 Q1	$170K	Buy	+2,789	New	+$166K	﹤0.01%	3986

Other funds holding IHI

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

PEAK6 Investments's IHI Position: Q3 2022 in Review

PEAK6 Investments sold out of iShares US Medical Devices ETF (IHI) in Q3 2022, closing a stake of 339 shares — an estimated $17K sold.

PEAK6 Investments first reported a position in IHI in Q1 2022 and held it in 2 quarters. The position peaked at $170K in Q1 2022. 556 funds tracked by Wall St. Rank hold IHI as of Q3 2022.

PEAK6 Investments reported no remaining iShares US Medical Devices ETF position as of Q3 2022 after selling out during the quarter.
PEAK6 Investments sold 339 iShares US Medical Devices ETF shares in Q3 2022, an estimated $17K.
PEAK6 Investments first reported a position in iShares US Medical Devices ETF in Q1 2022 and held it in 2 quarters.
PEAK6 Investments's iShares US Medical Devices ETF position peaked at $170K in Q1 2022.
556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2022.

Based on PEAK6 Investments's 13F filing for Q3 2022, filed 14 Nov 2022.